Replimune Group, Inc. (REPL)
NASDAQ: REPL · Real-Time Price · USD
19.07
-0.16 (-0.83%)
At close: Nov 20, 2026, 4:00 PM EST
19.20
+0.13 (0.68%)
After-hours: Nov 20, 2026, 7:51 PM EST
Replimune Group Market Cap
Replimune Group has a market cap or net worth of $1.81 billion as of November 20, 2026. It is the 6,630th most valuable company in the world and the 1,756th biggest in the United States. Its market cap has increased by 156.36% in one year.
Market Cap
1.81B
Enterprise Value
1.63B
1-Year Change
156.36%
Global Rank
Country Rank
#1,756 United States
Category
ChartMarket Cap Chart
Since July 20, 2018, Replimune Group's market cap has increased from $467.50M to $1.81B, an increase of 286.70%. That is a compound annual growth rate of 17.60%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2026 | 1.81B | 137.09% |
| Dec 31, 2025 | 762.50M | -7.97% |
| Dec 31, 2024 | 828.50M | 66.40% |
| Dec 29, 2023 | 497.90M | -63.20% |
| Dec 30, 2022 | 1.35B | 6.46% |
| Dec 31, 2021 | 1.27B | -27.53% |
| Dec 31, 2020 | 1.75B | 281.78% |
| Dec 31, 2019 | 459.30M | 45.58% |
| Dec 31, 2018 | 315.50M | -32.51% |
| Jul 20, 2018 (IPO) | 467.50M | - |
View and export this data all the way back to 2018. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Trevi Therapeutics | 1.90B |
| Biohaven | 1.87B |
| Immunome | 1.85B |
| Vera Therapeutics | 1.84B |
| Hemab Therapeutics Holdings | 1.84B |
| Septerna | 1.84B |
| Maravai LifeSciences Holdings | 1.81B |
| Zymeworks | 1.80B |